proteas defici plasma patient cystic fibrosi reduc reaction 4methylumbelliferylguanidinobenzo plasma patient cystic fibrosi proteas activ plasma assay use 4 methylumbelliferylguanidinobenzo assay modifi carri reaction presenc absenc benzamidin competit inhibitor trypsinlik proteas paramet assay describ detail use thi assay earlier demonstr defici proteas activ plasma patient cystic fibrosi confirm activ correct nonspecif hydrolysi 4 methylumbelliferylguanidinobenzo benzamidin express nanomol 4methylumbelliferon releas per millilit plasma standard condit activ plasma activ chloroformellag acid wa 1272 231 7 control 704 117 11 oblig heterozygot 487 166 12 patient cystic fibrosi ident result obtain unactiv plasma wa use data demonstr judici use specif inhibitor benzamidin might use assay low level proteas activ crude system